received funding from Novo Nordisk, Eli Lilly, Merck, Structure Therapeutics and Prostasis
Key Clinical Evidence Phase 2 Randomized Trial in Obesity (48 weeks) Jastreboff AM et al., New England Journal of Medicine, 2023 ClinicalTrials.gov: NCT04881760 The Phase 2 study evaluated multiple doses of retatrutide versus placebo over 48 weeks
People often describe BPC-157 as a healing peptide, and that description is directionally correct, but it does not capture the nuance
This blog will break down the benefits of Lipo-C, as well as the science behind it, so you can make an educated decision about whether or not this injection is suitable for you and your overall health
To help keep Wegovy at the right temperature while on the road, consider storing it in a thermal or insulated case or cooler